0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Research Letter |

Prescription Drug Abuse A National Survey of Primary Care Physicians FREE

Catherine S. Hwang, MSPH1,2; Lydia W. Turner, MHS1,2; Stefan P. Kruszewski, MD1,3,4; Andrew Kolodny, MD5; G. Caleb Alexander, MD, MS1,2,6
[+] Author Affiliations
1Center for Drug Safety and Effectiveness, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
2Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
3Department of Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
4Stefan P. Kruszewski, MD, and Associates, Harrisburg, Pennsylvania
5Phoenix House Foundation, New York, New York
6Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine, Baltimore, Maryland
JAMA Intern Med. 2015;175(2):302-304. doi:10.1001/jamainternmed.2014.6520.
Text Size: A A A
Published online

Chronic pain is one of the most common reasons for seeking medical attention in the United States, and such pain is frequently treated with prescription opioids. The clinical use of these products nearly doubled between 2000 and 2010,1 with simultaneous increases in the incidence of opioid abuse, addiction, injury, and death.2 Because primary care physicians play a critical role in maximizing the safe use of these products, we examined their beliefs and self-reported practices regarding prescription opioid use.

We used the Dillman3 approach to conduct a nationally representative postal mail survey. We sampled 1000 practicing US internists, family physicians, and general practitioners using the American Medical Association Masterfile. Participants were sent a questionnaire, $2 cash incentive, and self-addressed stamped envelope in February 2014, and nonrespondents were contacted a maximum of 3 times in approximately 6-week intervals. Response patterns between early and late responders were similar, suggesting the absence of nonresponse bias. However, because of modest sociodemographic differences between respondents and nonrespondents, we incorporated poststratification weights in our analyses. The questionnaire and study protocol were exempted from review by the institutional review board of the Johns Hopkins Bloomberg School of Public Health. The study did not require informed consent because it did not qualify as human subjects research.

Our adjusted response rate was 58%, and physician characteristics are reported in Table 1. Most physicians (90%) reported prescription drug abuse to be a “big” or “moderate” problem in their communities, and more than four-fifths (85%) reported that opioids are overused in clinical practice (Table 2). A majority of physicians (65%-84%) reported being “very” or “moderately” concerned about each potential adverse patient outcome that was assessed, including opioid-related addiction (55% reporting “very concerned”), deaths (48%), and motor vehicle accidents (44%). Furthermore, most physicians reported high frequencies of adverse events—such as tolerance (62% reported occurring “often”), physical dependence (56%), and ceiling effects (36%)—even when prescription opioids are used as directed to treat chronic pain. Physicians expressed somewhat lower degrees of concern for potential adverse prescriber outcomes associated with opioid prescribing, such as malpractice claims and censure by state medical boards. Approximately one-half of physicians (45%) reported being less likely to prescribe opioids compared to 1 year ago. Despite this, nearly all physicians (88%) expressed confidence in their clinical skills related to opioid prescribing, and nearly one-half (49%) were “very” or “moderately” comfortable using these drugs for chronic noncancer pain.

Table Graphic Jump LocationTable 1.  Physician Characteristics
Table Graphic Jump LocationTable 2.  Attitudes and Beliefs Regarding the Use of Opioids in Clinical Practice

Primary care physicians appear to recognize many elements of the prescription drug abuse epidemic, such as the high prevalence of adverse outcomes associated with opioid use.4,5 Although our study did not allow for longitudinal assessment of these physicians’ attitudes or knowledge over time, substantial publicity and raising of awareness on the part of many stakeholders may have contributed to these findings. Physicians’ high levels of confidence in their own prescribing are also of note and may reflect a combination of their experiences, as well as cognitive biases that have been demonstrated in other settings.6,7

Our study has limitations. First, our results are based on self-report and prone to socially desirable response bias. We minimized this potential by ensuring participant confidentiality and avoiding leading questions. Second, nonresponse bias may have influenced our findings. To reduce this impact, we maximized survey participation rates using the Dillman method and implemented poststratification weights in our analyses.

Given the increasing use of opioids in clinical practice and its attendant morbidity and mortality, understanding primary care physicians’ prescribing patterns, as well as their perception of adverse events associated with the use of these products, is crucial. Our investigation suggests that most primary care physicians are aware of many risks of opioids, and many have decreased their prescribing of these products during the past 12 months.

Corresponding Author: G. Caleb Alexander, MD, MS, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St, W6035, Baltimore, MD 21205 (galexand@jhsph.edu).

Published Online: December 8, 2014. doi:10.1001/jamainternmed.2014.6520.

Author Contributions: Ms Hwang and Dr Alexander had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.

Study concept and design: All authors.

Acquisition, analysis, or interpretation of data: Hwang, Turner, Kolodny, Alexander.

Drafting of the manuscript: Hwang, Turner, Kolodny, Alexander.

Critical revision of the manuscript for important intellectual content: Hwang, Kruszewski, Kolodny, Alexander.

Statistical analysis: Hwang, Kolodny.

Obtained funding: Turner, Alexander.

Administrative, technical, or material support: Turner, Kruszewski, Alexander.

Study supervision: Turner, Alexander.

Conflict of Interest Disclosures: Ms Hwang is a current ORISE Fellow at the Food and Drug Administration. Dr Kruszewski has served as a general and case-specific expert for multiple plaintiff litigations involving OxyContin, Neurontin, and Zyprexa and has had false claims settled as coplaintiff with the United States against Southwood Psychiatric Hospital, Pfizer (Geodon), and AstraZeneca (Seroquel). Dr Kolodny is employed by the Phoenix House and is President of Physicians for Responsible Opioid Prescribing. Dr Alexander is Chair of the Food and Drug Administration’s Peripheral and Central Nervous System Drugs Advisory Committee, serves as a paid consultant to IMS Health, and serves on an IMS Health scientific advisory board. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. No other disclosures are reported.

Funding/Support: This work was supported by the Robert Wood Johnson Foundation Public Health Law Research Program and the Lipitz Public Health Policy Fund Award from the Johns Hopkins Bloomberg School of Public Health.

Role of the Sponsor: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Additional Contributions: Kenneth Rasinski, PhD, Joint Commission, provided helpful input on survey development, fielding, and analysis. He was not compensated for his contribution.

Daubresse  M, Chang  HY, Yu  Y,  et al.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51(10):870-878.
PubMed   |  Link to Article
Centers for Disease Control and Prevention. Prescription Drug Overdose in the United States: Fact Sheet. Updated October 17, 2014. http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html. Accessed October 22, 2014.
Dillman  DA. Mail and Telephone Surveys: the Total Design Method. New York, NY: John Wiley and Sons; 1978.
Juurlink  DN, Dhalla  IA.  Dependence and addiction during chronic opioid therapy. J Med Toxicol. 2012;8(4):393-399.
PubMed   |  Link to Article
Benyamin  R, Trescot  AM, Datta  S,  et al.  Opioid complications and side effects. Pain Physician. 2008;11(2)(suppl):S105-S120.
PubMed
Dawson  NV, Arkes  HR.  Systematic errors in medical decision making: judgment limitations. J Gen Intern Med. 1987;2(3):183-187.
PubMed   |  Link to Article
Poses  RM, McClish  DK, Bekes  C, Scott  WE, Morley  JN.  Ego bias, reverse ego bias, and physicians’ prognostic. Crit Care Med. 1991;19(12):1533-1539.
PubMed   |  Link to Article

Figures

Tables

Table Graphic Jump LocationTable 1.  Physician Characteristics
Table Graphic Jump LocationTable 2.  Attitudes and Beliefs Regarding the Use of Opioids in Clinical Practice

References

Daubresse  M, Chang  HY, Yu  Y,  et al.  Ambulatory diagnosis and treatment of nonmalignant pain in the United States, 2000-2010. Med Care. 2013;51(10):870-878.
PubMed   |  Link to Article
Centers for Disease Control and Prevention. Prescription Drug Overdose in the United States: Fact Sheet. Updated October 17, 2014. http://www.cdc.gov/homeandrecreationalsafety/overdose/facts.html. Accessed October 22, 2014.
Dillman  DA. Mail and Telephone Surveys: the Total Design Method. New York, NY: John Wiley and Sons; 1978.
Juurlink  DN, Dhalla  IA.  Dependence and addiction during chronic opioid therapy. J Med Toxicol. 2012;8(4):393-399.
PubMed   |  Link to Article
Benyamin  R, Trescot  AM, Datta  S,  et al.  Opioid complications and side effects. Pain Physician. 2008;11(2)(suppl):S105-S120.
PubMed
Dawson  NV, Arkes  HR.  Systematic errors in medical decision making: judgment limitations. J Gen Intern Med. 1987;2(3):183-187.
PubMed   |  Link to Article
Poses  RM, McClish  DK, Bekes  C, Scott  WE, Morley  JN.  Ego bias, reverse ego bias, and physicians’ prognostic. Crit Care Med. 1991;19(12):1533-1539.
PubMed   |  Link to Article

Correspondence

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

3,222 Views
4 Citations
×

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
Jobs
JAMAevidence.com

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Original Article: Can the Clinical History Distinguish Between Organic and Functional Dyspepsia?

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Results